ArticleUrology research & practice2026

Targeting Human Epidermal Growth Factor Receptor 2 in Bladder Cancer: Evaluating Its Role as a More Robust Clinicopathological Biomarker Compared to Programmed Death Ligand 1 Expression.

Ankur Mittal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.